What is the effect of a stabilising group treatment in complex PTSD patients? A Multicenter Randomised Clinical Trial for women with Child Abuse related Post Traumatic Stress Disorder with Associated Features.

The effectiveness of a stabilising group treatment in females with complex PTSD patients: A Multicenter Randomised Controlled Trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27986

Enrollment

Registered

2006-03-17

Start date

2006-03-20

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stabilising group therapy vs treatment as usual

Interventions

20-week group stabilising treatment for complex PTSD plus TAU vs TAU alone.

Eligibility

Inclusion criteria

Inclusion criteria: Females diagnosed with Complex PTSD according to SCID-DESNOS with or without comorbid axis I or axis II disorders (see also exclusion criteria).

Exclusion criteria

Exclusion criteria: Comorbid psychotic disorders, substance dependence; antisocial personality disorder or dissociative identity disorder, all diagnosed with SCID-I, SCID-D or SCID-II.

Design outcomes

Primary

Measure	Time frame
1. CAPS and Davidson Trauma Scale (severity of PTSD symptoms); 2. SCID-DESNOS (overall severity of complex PTSD symptoms); 3. Borderline Personality Disorder Severity Index (BPDSI) (severity of affect-dysregulation and selfdestructiveness); 4. Dissociative Experiences Scale (DES).	—

Secondary

Measure	Time frame
1. SE (Self Esteem measure); 2. SDQ (somatic dissociation); 3. WHO- QoL (Quality of Life); 4. SCL-90 (comorbid psychopathology); 5. BDI (depression); 6. STAI (anxiety).	—

Contacts

Public ContactA.J.L.M. Balkom, van

VU University Medical Center Department of Psychiatry / GGZ Buitenamstel

vanbalkom@ggzba.nl+31 (0)20 7884549

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)